Tricyclene is a compact bicyclic monoterpene hydrocarbon most relevant in the AromaForge archive as a conifer-style composition marker rather than as a benefit-led active. Live sources strongly support its chemical identity and its repeated occurrence in fir, hemlock, spruce, tansy, and occasional high-tricyclene chemotypes. Direct isolated-compound pharmacology and modern safety literature are sparse, so archive framing should stay chemistry-first and explicit about evidence gaps.
Aroma and practical use
- Use the recorded piney, terpenic, camphoraceous, coniferous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2022 GC-MS study of Salvia aegyptiaca from the Algerian pre-Sahara reported tricyclene at 22.9% and proposed a new high-tricyclene chemotype.
A 2022 GC-MS study of Salvia aegyptiaca from the Algerian pre-Sahara reported tricyclene at 22.9% and proposed a new high-tricyclene chemotype.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2003 eastern hemlock volatile-emissions paper identified tricyclene among the released monoterpenes and found that insect infestation increased overall monoterpene release rates.
A 2003 eastern hemlock volatile-emissions paper identified tricyclene among the released monoterpenes and found that insect infestation increased overall monoterpene release rates.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2000 Finnish tansy survey reported a mixed chemotype containing tricyclene and myrcene for the first time in that geographic set.
A 2000 Finnish tansy survey reported a mixed chemotype containing tricyclene and myrcene for the first time in that geographic set.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
This pass did not verify a dedicated modern RIFM or IFRA-style public safety assessment for isolated tricyclene.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
No constituent-specific dermal maximum, sensitization threshold, or clinical topical-use study was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
volatile_ecology_marker
The strongest mechanism-adjacent evidence in this pass is ecological rather than pharmacologic: tricyclene appears within plant volatile blends whose emission rates shift under herbivore or infestation pressure.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (4)
- No strong human clinical, pharmacology, or aromatherapy-outcome literature focused on isolated tricyclene was verified in this pass.
- Public evidence is much stronger for plant occurrence and chemotype work than for constituent-specific safety characterization.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.